Effect of rivastigmine or memantine add-on therapy is affected by butyrylcholinesterase genotype in patients with probable Alzheimer's disease.
2015
Background: The K variant of butyrylcholinesterase (BCHE-K) exhibits a reduced acetylcholine-hydrolyzing capacity; so the clinical response to
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
14
Citations
NaN
KQI